Euclidean Capital’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Hold |
2,627,643
| – | – | 0.91% | 5 |
|
|
2025
Q1 | $2.86M | Hold |
2,627,643
| – | – | 1.08% | 5 |
|
|
2024
Q4 | $3.97M | Hold |
2,627,643
| – | – | 0.54% | 6 |
|
|
2024
Q3 | $3.92M | Hold |
2,627,643
| – | – | 0.43% | 7 |
|
|
2024
Q2 | $4.26M | Hold |
2,627,643
| – | – | 0.53% | 6 |
|
|
2024
Q1 | $4.47M | Hold |
2,627,643
| – | – | 0.57% | 10 |
|
|
2023
Q4 | $8.15M | Hold |
2,627,643
| – | – | 0.92% | 9 |
|
|
2023
Q3 | $16.1M | Buy |
2,627,643
+82,401
| +3% | +$506K | 3.52% | 4 |
|
|
2023
Q2 | $15.9M | Buy |
2,545,242
+208,333
| +9% | +$1.3M | 4.09% | 5 |
|
|
2023
Q1 | $11.1M | Hold |
2,336,909
| – | – | 9.78% | 3 |
|
|
2022
Q4 | $20.3M | Hold |
2,336,909
| – | – | 19.02% | 3 |
|
|
2022
Q3 | $27.8M | Hold |
2,336,909
| – | – | 25.82% | 2 |
|
|
2022
Q2 | $33.3M | Hold |
2,336,909
| – | – | 28.32% | 1 |
|
|
2022
Q1 | $48.7M | Hold |
2,336,909
| – | – | 28.27% | 1 |
|
|
2021
Q4 | $54M | Sell |
2,336,909
-432,904
| -16% | -$10M | 30.69% | 1 |
|
|
2021
Q3 | $82.5M | Sell |
2,769,813
-1,138,864
| -29% | -$33.9M | 40.12% | 1 |
|
|
2021
Q2 | $134M | Sell |
3,908,677
-270,739
| -6% | -$9.25M | 43.34% | 1 |
|
|
2021
Q1 | $137M | Hold |
4,179,416
| – | – | 45.99% | 1 |
|
|
2020
Q4 | $257M | Buy |
+4,179,416
| New | +$257M | 54.42% | 1 |
|